Hhlr Advisors, Ltd. Cytokinetics Inc Call Options Transaction History
Hhlr Advisors, Ltd.
- $4.36 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
410Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$762 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$611 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$503 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$404 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$335 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.89B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...